Trials are underway to evaluate an affordable hepatitis C treatment. So far, the therapy has been shown to be safe and effective, with very high cure rates for patients including hard-to-treat cases. The interim clinical trial results offers hope to the 71 million people living with the disease worldwide. The Drugs for Neglected Diseases initiative (DNDi), a
There is sometimes heated discussion about adherence to medical regimens being of value, both to an individual patient and to broader patient categories. Inflammatory bowel disease is certainly one of these contentious areas. Patients often seem to go from doctor to doctor, seeking out one who agrees with the decisions they have already made. Even
